Market Research Report
Antifungal Drugs: Technologies and Global Markets
|Published by||BCC Research||Product code||117625|
|Published||Content info||272 Pages
The global market for antifungal drugs was valued at $13.1 billion in 2016. The market should reach $16.1 billion by 2021, growing at a compound annual growth rate (CAGR) of 4.2% from 2016 to 2021.
The aim of this report is to initially conduct a review of the antifungal drugs currently available, the issues facing the use of antifungal drugs and review some of the latest developments of new and innovative antifungal drugs, their technologies, and their intended clinical applications.
The key objective was also to conduct and provide an analysis of the market value, growth rates, market shares, market development as well as examining the market dynamics and market factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry, and the factors influencing the market shares of the major market suppliers as well as smaller indigenous manufactures in local markets. The emphasis of this report is to provide the reader with:
In addition this analysis provides a:
The study will allow the reader to:
The author is an independent market analyst for the medical industry with a BSc and PhD in Biochemistry from the University of Liverpool and an MBA from Oxford Brookes University. The author has worked in the medical industry as a senior marketing executive for 20 years creating and implementing strategic business and marketing plans for major multinational medical device companies before establishing himself as an independent research analyst.
For the last 15 years the author has worked extensively in managing and conducting market research projects in key markets amongst healthcare professionals to determine market conditions, product attributes, issues and opinions. This data and information has been used to analyze specific product global market segments, create and implement strategic business and marketing plans for major multinational companies to launch new products and product line extensions, as well as re-marketing existing product lines.
The author has also acquired knowledge and experience with a wide range of software applications including windows office based applications including Microsoft Word, Excel, PowerPoint and Project, as well as more specific predictive analytical software such as SPSS, Stata and SAS, as a means of obtaining logistic regression, statistical variance analysis and mixed model analysis of market research data. This form of analysis has been used recently to prepare a variety of bespoke customized strategic marketing plans for individual clients in the biopharmaceutical and biotechnology industries.